Navigation Links
Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
Date:12/14/2008

rence is 'low' or 'high'," said Dr. Sgroi. "The ability to reduce the number of patients in the 'intermediate' group by reclassifying them as either 'high' or 'low' risk, making risk prediction more specific, should go a long way in helping medical professionals select the most appropriate therapy for each of their patients."

On Saturday, Matthew Goetz, M.D., from Mayo Clinic and colleagues from Austria presented data examining the predictive utility of CYP2D6 and the prognostic utility of the Theros Breast Cancer Index in women with breast cancer randomized to receive five years of treatment with tamoxifen or two years of tamoxifen followed by three years anastrozole treatment. The researchers found that the Theros Breast Cancer Index will identify, among patients with early stage breast cancer, those with a higher risk of treatment failure when treated only with hormonal therapy. They concluded that the Theros Breast Cancer Index identified approximately 25 percent of grade 1 and grade 2 breast cancers that had a nearly three-fold higher risk for a subsequent recurrence in distant organs.

Finally, data from a study presented on Sunday by Olle Stal, PhD, and colleagues from Linkoping University in Sweden explored the value of the HOXB13 gene in predicting benefit of tamoxifen therapy. Researchers reviewed HOXB13 protein expression in tumor samples from 866 patients with estrogen- receptor positive tumors. Patients whose tumors expressed no or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival. Patients with a high or intermediate HOXB13 expression did not experience a distant recurrence-free survival benefit from tamoxifen as compared to untreated patients.

"Data from these studies reinforce clinical and research experience to date which has shown that the Theros Breast Cancer Index is an excellent test for assessing breast cancer risk prognosi
'/>"/>

SOURCE bioTheranostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. (NYSE ... closing of its offering of $125 million aggregate principal ... "Notes").  The Notes were offered and sold only to ... Securities Act of 1933, as amended (the "Securities Act"). ... rate of 3.75% per year, payable semiannually in arrears ...
(Date:12/17/2014)... 17, 2014 PCCA received the Autism ... http://bit.ly/1382OkS ) program seal for best practices in ... highlights medical practices, materials and goods that meet ... Children affected by autism often have unique ... by ingredients found in food and medicine – ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 19, 2012 Uroplasty, Inc. (NASDAQ: UPI ) ... third quarter of fiscal 2012 ended December 31, 2011, at ... will host a conference call to discuss these results on ... p.m. Central Time). David Kaysen, President and Chief Executive Officer, ...
... MINNEAPOLIS, Jan. 19, 2012 /PRNewswire-iReach/ -- Today, ... the 4th Annual TripleTree iAwards for Wireless Health ... impactful mobile and wireless solutions in the healthcare industry. ... be accepted through March 30, 2012.  Each application will ...
Cached Medicine Technology:Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012 2Call for Submissions: 2012 TripleTree iAwards for Wireless Health 2Call for Submissions: 2012 TripleTree iAwards for Wireless Health 3
(Date:12/19/2014)... TX (PRWEB) December 19, 2014 ... a shifting, capital equipment market that is saturated ... impressive safety and efficacy as well as non-invasive ... they were first introduced to the healthcare market. ... the development of MRI safe technologies have greatly ...
(Date:12/19/2014)... 2014 From November 24, 2014, Siddhi ... the year 2014 in its Goa retreat . This ... the Indian winters, from November to March, Siddhi Yoga will ... of Arambol, Goa. The Goa training sessions will conclude in ... yoga teacher training, the 10th intake is also a ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Dr. Myo Nwe ... Weight Loss Diet of the Future” and co-founder of the ... her book, Dr. Nwe takes a broad look at the ... hold up under scientific scrutiny. On film and in television ... emphasized mostly toward the social aspects and played for basic ...
Breaking Medicine News(10 mins):Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 2Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 3Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 4Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2
... OAK BROOK, Ill. April 25, 2011 A ... acid suppression is a safe and effective method to ... adenocarcinoma (cancer) or high-grade dysplasia of the esophagus developed ... largest published series and longest follow-up of patients with ...
... , MONDAY, April 25 (HealthDay News) -- Some college students ... reruns during the TV writers, strike of 2007-2008, a new ... use television for companionship -- as opposed to simply for ... characters on the tube, the study authors noted. "We ...
... R.I. [Brown University] A new study of sexual ... that HIV-positive people take almost as much risk in ... HIV-negative or don,t know their status, as when they ... time, HIV-positive partners who are on antiretroviral therapy and ...
... Ga. Decreasing blood levels of a protein that ... could help children avoid type 1 diabetes, researchers say. ... levels of interleukin-1 receptor antagonist, or IL-1ra, in children ... risk for type 1 diabetes. They also are looking ...
... Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: ... Food and Drug Administration (FDA) has granted licensure to ... (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria ... infants and children 9 months through 23 months of ...
... MONDAY, April 25 (HealthDay News) -- Acupuncture might help ... patients while they,re on hormone therapy, a small study ... ancient Chinese discipline relieves hot flashes, and only 14 ... researchers at New York Methodist Hospital and Weill Cornell ...
Cached Medicine News:Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 2Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 3Health News:Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus 4Health News:Some TV Fans 'Distressed' Without Favorite Shows: Study 2Health News:Fighting HIV in South Africa should focus on couples, study finds 2Health News:Fighting HIV in South Africa should focus on couples, study finds 3Health News:Protein levels could signal that a child will develop diabetes 2Health News:Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants 2Health News:Acupuncture May Help Ease Hot Flashes Tied to Prostate Cancer Treatment 2
For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...
Fine & Medium Tapers....
Contour Design Eyelid Implants....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Medicine Products: